Association between Lipoprotein Subfractions, Hemostatic Potentials, and Coronary Atherosclerosis
Table 1
Baseline patient characteristics based on calcium score categories.
Overall
CACS 1-300
value
Age (years)
63 (56-71)
56 (49-63)
66 (58-72)
71 (66-75)
<0.001
Sex (women)
84 (52.5%)
42 (64,6%)
31 (45.6%)
11 (40.7%)
0.024
Arterial hypertension
73 (45.6%)
23 (35.4%)
39 (57.4%)
11 (40.7%)
<0.001
Dyslipidemia
54 (33.8%)
12 (18.5%)
29 (42.6%)
13 (48.1%)
0.002
Diabetes
16 (10.0%)
3 (4.6%)
6 (8.8%)
7 (25.9%)
0.005
Family history
87 (54.4%)
39 (60.0%)
31 (45.6%)
17 (63.0%)
0.105
Smoking
No
86 (53.8%)
44 (67.7%)
32 (47.1%)
10 (37.0%)
0.057
Active
16 (10.0%)
4 (6.2%)
8 (11.8%)
4 (14.8%)
Former
52 (32.5%)
15 (23.1%)
26 (38.2%)
11 (40.7%)
Physical inactivity
101 (63.1%)
40 (61.5%)
45 (66.2%)
16 (59.3%)
0.859
HDL3
223 (196-257)
240 (221-269)
226 (196-257)
198 (174-218)
0.010
LDL
123 (97-147)
118 (89-147)
125 (104-147)
118 (97-124)
0.326
sdLDL
261 (212-369)
260 (234-376)
282 (206-365)
252 (163-322)
0.544
TAS
1.69 (1.54-1.74)
1.55 (1.49-1.66)
1.64 (1.56-1.73)
1.76 (1.59-1.88)
0.042
OHP
5.30 (3.80-7.84)
4.75 (2.91-8.44)
5.35 (4.28-7.55)
5.70 (4.96-7.48)
0.541
OCP
22.6 (18.9-22.0)
20.9 (17.5-25.1)
23-2 (19.4-27.1)
24.2 (21.7-28.7)
0.131
OFP
73.6 (66.6-80.0)
75.6 (63.1-80.1)
71.6 (68.6-77.7)
74.7 (22.8-81.0)
0.592
CACS: coronary artery calcium score; HDL3: high-density lipoprotein type 3; LDL; low-density lipoprotein; sdLDL: small dense low-density lipoprotein; TAS: total antioxidant status; OHP/OCP/OFP: overall hemostatic/coagulation/fibrinolytic potential. denotes significant difference at a <0.05 level between groups CACS 0 vs. CACS 1-300 on post hoc analysis; denotes significant difference at a <0.05 level between groups CACS 1-300 vs. on post hoc analysis.
